Managing Director at Asphalion
Pharmacy, Quality Management and MBA degree.
More than 15 years as Regulatory Affairs Consultant and Operations.
Academic research experience in pharmacy and microbiology.
General Manager, Regulatory Affairs at Asphalion since 2000.
Pharmacy and MBA degree.
More than 15 years’ overall experience in pharmaceutical industry.
10 years as Regulatory Affairs Director.
4 years as Vice-Director for Research and Development.
Board member of CataloniaBio&HealthTech
Board Member and Scientific Advisor at Asphalion.
PhD in Chemistry, Pharmacy and MBA.
15 years University Professor in the field of Pharmaceutical Chemistry.
10 years Director of Research & Development in pharmaceutical industry.
16 years General Manager of Asphalion.
8 years expert group member for European Pharmacopoeia.
Regulatory Affairs Director at Asphalion since 2005.
PhD in Pharmacy.
Academic research experience in pharmaceutical chemistry.
More than 10 years’ experience in Regulatory Affairs in industry.
Regulatory Affairs Director in Asphalion since 2004.
Drug Safety Director.
PhD in Pharmacy.
Academic research experience
Broad scientific background in the area of microbiology and pharmacy.
Regulatory Information Director at Asphalion since 2011
and Commercial Director since 2017.
Degree in Management, Economics & Law. Working in Regulatory Affairs since 1999. Industry experience with focus on global submission procedures, eSubmission and Regulatory Information Management.
Chairmain of Industry workgroup for Telematic since 2007.
Director of Asphalion’s Munich Office since 2013.
Academic research experience.
7 years as Regulatory Affairs Consultant and Business Development Director in Asphalion.
Regulatory Affairs Director at Asphalion since 2010.
Pharmacy and business degree.
25+ years overall industry experience
Regulatory Affairs positions in 4 different pharmaceutical companies, including Head of Regulatory Affairs.
Director of Asphalion’s Madrid Office since 2018.
PharmD degree. CMC expert. Over 12+ years’ experience in Regulatory Affairs and Product Lifecycle Management of Human Medicinal Products in different pharmaceutical companies and business models.